Abstract

The highly pathogenic avian influenza (HPAI) virus subtype H5N1 has been found to be the most virulent and deadliest virus strain, with capability of interspecies transmission to human infection. Most human HPAI H5N1 cases were diagnosed late in their illnesses for medical care, resulting in severe complications that led to death. In this study, a novel graphene-enhanced electrochemical DNA biosensor had been fabricated for the detection of polymerase chain reaction (PCR) amplicon derived from the haemagglutinin (H5) gene of the HPAI. The graphene-enhanced DNA biosensor showed excellent linear correlation between PCR amplicon concentration and amperometric signal with a correlation coefficient, r2 of 0.9987. The amperometric response of the proposed biosensor was compared with conventional gel electrophoresis while the feasibility of the proposed sandwich sensing platform was verified via dot blot assay. The results obtained indicate that the electrochemical DNA biosensing assay is significantly more sensitive (P < 0.05) and time efficient. This work serves as a proof of concept in hopes for further development of the graphene enhanced electrochemical DNA biosensor into a portable, on-site screening platform for point-of-care detection of various pathogens.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.